SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern.
Ji Yun Noh, Hye Won Jeong, Eui-Cheol Shin
Author Information
- Ji Yun Noh: Division of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
- Hye Won Jeong: Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
- Eui-Cheol Shin: Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea. ecshin@kaist.ac.kr.
No abstract text available.
- Nature. 2021 Apr;592(7855):616-622
[PMID: 33567448]
- Sci Immunol. 2021 Mar 4;6(57):
[PMID: 33664060]
- Nat Med. 2021 Apr;27(4):717-726
[PMID: 33664494]
- Nature. 2021 May;593(7857):130-135
[PMID: 33684923]
- HI20C0452/Korea Health Industry Development Institute (KHIDI)
- 2020R1A5A2017476/National Research Foundation of Korea (NRF)
COVID-19
Humans
Mutation
RNA, Messenger
SARS-CoV-2
Vaccines
